nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNQ1—TarBasePathway—ERG—bone cancer	0.193	0.197	CbGpPWpGaD
Dalfampridine—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.0401	0.0409	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—FEV—bone cancer	0.0371	0.0378	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—bone cancer	0.0309	0.0315	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0195	0.0199	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TNFRSF11A—bone cancer	0.017	0.0174	CbGpPWpGaD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.0164	0.0168	CbGpPWpGaD
Dalfampridine—KCNC2—Regulation of insulin secretion—GNA11—bone cancer	0.0164	0.0167	CbGpPWpGaD
Dalfampridine—KCNG2—Regulation of insulin secretion—GNA11—bone cancer	0.0164	0.0167	CbGpPWpGaD
Dalfampridine—KCNS3—Regulation of insulin secretion—GNA11—bone cancer	0.0164	0.0167	CbGpPWpGaD
Dalfampridine—KCNB1—Regulation of insulin secretion—GNA11—bone cancer	0.0155	0.0159	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—EIF2S1—bone cancer	0.0142	0.0145	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—FEV—bone cancer	0.0137	0.014	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0132	0.0134	CbGpPWpGaD
Dalfampridine—KCNG2—Integration of energy metabolism—GNA11—bone cancer	0.0129	0.0132	CbGpPWpGaD
Dalfampridine—KCNS3—Integration of energy metabolism—GNA11—bone cancer	0.0129	0.0132	CbGpPWpGaD
Dalfampridine—KCNC2—Integration of energy metabolism—GNA11—bone cancer	0.0129	0.0132	CbGpPWpGaD
Dalfampridine—KCNB1—Integration of energy metabolism—GNA11—bone cancer	0.0122	0.0125	CbGpPWpGaD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00917	0.00936	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL3—bone cancer	0.00806	0.00822	CbGpPWpGaD
Dalfampridine—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00759	0.00775	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00711	0.00726	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—GNA11—bone cancer	0.0066	0.00674	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—EZH2—bone cancer	0.00657	0.00671	CbGpPWpGaD
Dalfampridine—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00635	0.00648	CbGpPWpGaD
Dalfampridine—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.00611	0.00624	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—GNA11—bone cancer	0.00577	0.00589	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—EZH2—bone cancer	0.00574	0.00586	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.00566	0.00578	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NDUFA12—bone cancer	0.00469	0.00478	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NDUFA12—bone cancer	0.00469	0.00478	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NDUFA12—bone cancer	0.00469	0.00478	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—JUN—bone cancer	0.0045	0.0046	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NDUFA12—bone cancer	0.00444	0.00453	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00415	0.00424	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—BRAF—bone cancer	0.00409	0.00417	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NT5C3A—bone cancer	0.00388	0.00396	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NT5C3A—bone cancer	0.00388	0.00396	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NT5C3A—bone cancer	0.00388	0.00396	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—CDK4—bone cancer	0.00371	0.00379	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NT5C3A—bone cancer	0.00368	0.00376	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—BRAF—bone cancer	0.00364	0.00372	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—BRAF—bone cancer	0.00348	0.00355	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—BRAF—bone cancer	0.00348	0.00355	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—MDM2—bone cancer	0.00342	0.0035	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.00326	0.00333	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—CDK4—bone cancer	0.00324	0.00331	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—MDM2—bone cancer	0.00305	0.00312	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—JUN—bone cancer	0.00293	0.00299	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—BRAF—bone cancer	0.00291	0.00297	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—BRAF—bone cancer	0.00291	0.00297	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—BRAF—bone cancer	0.00291	0.00297	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—MDM2—bone cancer	0.00291	0.00297	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—MDM2—bone cancer	0.00291	0.00297	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—BRAF—bone cancer	0.00283	0.00289	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—BRAF—bone cancer	0.00276	0.00282	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00264	0.00269	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.0026	0.00266	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—BRAF—bone cancer	0.00252	0.00258	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—BRAF—bone cancer	0.00252	0.00258	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—bone cancer	0.00252	0.00258	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—bone cancer	0.00252	0.00258	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—BRAF—bone cancer	0.00248	0.00253	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MDM2—bone cancer	0.00244	0.00249	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MDM2—bone cancer	0.00244	0.00249	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MDM2—bone cancer	0.00244	0.00249	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—JUN—bone cancer	0.00239	0.00244	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MDM2—bone cancer	0.00237	0.00242	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MDM2—bone cancer	0.00231	0.00236	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—BRAF—bone cancer	0.00224	0.00229	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—BRAF—bone cancer	0.00221	0.00225	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00214	0.00218	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MDM2—bone cancer	0.00212	0.00216	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MDM2—bone cancer	0.00212	0.00216	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—JUN—bone cancer	0.00209	0.00213	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MDM2—bone cancer	0.00207	0.00212	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MET—bone cancer	0.00188	0.00192	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—bone cancer	0.00188	0.00192	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—BRAF—bone cancer	0.00188	0.00192	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BRAF—bone cancer	0.00188	0.00192	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MDM2—bone cancer	0.00188	0.00192	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MDM2—bone cancer	0.00185	0.00189	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ENO2—bone cancer	0.0017	0.00174	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ENO2—bone cancer	0.0017	0.00174	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ENO2—bone cancer	0.0017	0.00174	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO2—bone cancer	0.00161	0.00165	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—bone cancer	0.00158	0.00161	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DHFR—bone cancer	0.00158	0.00161	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DHFR—bone cancer	0.00158	0.00161	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DHFR—bone cancer	0.00158	0.00161	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MDM2—bone cancer	0.00157	0.0016	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MDM2—bone cancer	0.00157	0.0016	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—bone cancer	0.00157	0.0016	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—bone cancer	0.00157	0.0016	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.0015	0.00153	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—DHFR—bone cancer	0.0015	0.00153	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNA11—bone cancer	0.00147	0.00151	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNA11—bone cancer	0.00147	0.00151	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNA11—bone cancer	0.00147	0.00151	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNA11—bone cancer	0.0014	0.00143	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—bone cancer	0.00138	0.00141	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CDK4—bone cancer	0.00134	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CDK4—bone cancer	0.00134	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—bone cancer	0.00134	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—bone cancer	0.00134	0.00137	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP3A4—bone cancer	0.00134	0.00136	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP3A4—bone cancer	0.00134	0.00136	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP3A4—bone cancer	0.00134	0.00136	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP3A4—bone cancer	0.00127	0.00129	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—bone cancer	0.00118	0.0012	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—bone cancer	0.00118	0.0012	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—bone cancer	0.00114	0.00117	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—bone cancer	0.00114	0.00117	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—bone cancer	0.00114	0.00117	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.00114	0.00116	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.00112	0.00114	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—bone cancer	0.00112	0.00114	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—bone cancer	0.00112	0.00114	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—bone cancer	0.00108	0.00111	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.00108	0.00111	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000971	0.000992	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000958	0.000978	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—bone cancer	0.000953	0.000973	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—bone cancer	0.000953	0.000973	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—bone cancer	0.000934	0.000954	CbGpPWpGaD
Dalfampridine—Infection—Carboplatin—bone cancer	0.000883	0.0435	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—bone cancer	0.000842	0.000859	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—bone cancer	0.000842	0.000859	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—bone cancer	0.000783	0.000799	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000681	0.000695	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—bone cancer	0.00068	0.000694	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—bone cancer	0.00068	0.000694	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—bone cancer	0.000592	0.000605	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—bone cancer	0.000592	0.000605	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—bone cancer	0.000592	0.000605	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NT5C3A—bone cancer	0.000564	0.000576	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—bone cancer	0.000562	0.000573	CbGpPWpGaD
Dalfampridine—Nasopharyngitis—Cisplatin—bone cancer	0.000474	0.0234	CcSEcCtD
Dalfampridine—Connective tissue disorder—Cisplatin—bone cancer	0.000361	0.0178	CcSEcCtD
Dalfampridine—Immune system disorder—Cisplatin—bone cancer	0.000332	0.0163	CcSEcCtD
Dalfampridine—Mediastinal disorder—Cisplatin—bone cancer	0.000331	0.0163	CcSEcCtD
Dalfampridine—Tremor—Cisplatin—bone cancer	0.000299	0.0147	CcSEcCtD
Dalfampridine—Convulsion—Cisplatin—bone cancer	0.000277	0.0136	CcSEcCtD
Dalfampridine—Anxiety—Cisplatin—bone cancer	0.000271	0.0133	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00027	0.0133	CcSEcCtD
Dalfampridine—Anaphylactic shock—Cisplatin—bone cancer	0.000261	0.0128	CcSEcCtD
Dalfampridine—Infection—Cisplatin—bone cancer	0.000259	0.0128	CcSEcCtD
Dalfampridine—Nervous system disorder—Cisplatin—bone cancer	0.000256	0.0126	CcSEcCtD
Dalfampridine—Skin disorder—Cisplatin—bone cancer	0.000253	0.0125	CcSEcCtD
Dalfampridine—CYP2E1—Metabolism—ENO2—bone cancer	0.000247	0.000252	CbGpPWpGaD
Dalfampridine—Hypotension—Cisplatin—bone cancer	0.000244	0.012	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—bone cancer	0.000244	0.012	CcSEcCtD
Dalfampridine—Paraesthesia—Cisplatin—bone cancer	0.000234	0.0115	CcSEcCtD
Dalfampridine—Dyspnoea—Cisplatin—bone cancer	0.000232	0.0114	CcSEcCtD
Dalfampridine—CYP2E1—Metabolism—DHFR—bone cancer	0.000229	0.000234	CbGpPWpGaD
Dalfampridine—Nasopharyngitis—Doxorubicin—bone cancer	0.000225	0.0111	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000225	0.0111	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—bone cancer	0.000224	0.011	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—bone cancer	0.000224	0.011	CcSEcCtD
Dalfampridine—Feeling abnormal—Cisplatin—bone cancer	0.000215	0.0106	CcSEcCtD
Dalfampridine—CYP2E1—Metabolism—GNA11—bone cancer	0.000214	0.000219	CbGpPWpGaD
Dalfampridine—Infestation NOS—Epirubicin—bone cancer	0.00021	0.0103	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—bone cancer	0.00021	0.0103	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—bone cancer	0.000204	0.01	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—bone cancer	0.000194	0.00956	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—bone cancer	0.000194	0.00956	CcSEcCtD
Dalfampridine—CYP2E1—Metabolism—CYP3A4—bone cancer	0.000194	0.000198	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Cisplatin—bone cancer	0.000192	0.00946	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—bone cancer	0.000189	0.0093	CcSEcCtD
Dalfampridine—Asthenia—Cisplatin—bone cancer	0.000187	0.00921	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—bone cancer	0.000185	0.00912	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—bone cancer	0.000183	0.00899	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—bone cancer	0.000182	0.00895	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—bone cancer	0.000182	0.00894	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—bone cancer	0.000176	0.00869	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—bone cancer	0.000171	0.00844	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—bone cancer	0.000171	0.00842	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—bone cancer	0.00017	0.00838	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—bone cancer	0.00017	0.00836	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—bone cancer	0.00017	0.00835	CcSEcCtD
Dalfampridine—CYP2E1—Metabolism—GSTP1—bone cancer	0.000166	0.00017	CbGpPWpGaD
Dalfampridine—Vomiting—Cisplatin—bone cancer	0.000166	0.00816	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—bone cancer	0.000165	0.00813	CcSEcCtD
Dalfampridine—Rash—Cisplatin—bone cancer	0.000164	0.00809	CcSEcCtD
Dalfampridine—Dermatitis—Cisplatin—bone cancer	0.000164	0.00809	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—bone cancer	0.000159	0.00781	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—bone cancer	0.000158	0.00779	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—bone cancer	0.000158	0.00775	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—bone cancer	0.000157	0.00774	CcSEcCtD
Dalfampridine—Nausea—Cisplatin—bone cancer	0.000155	0.00762	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—bone cancer	0.000153	0.00752	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—bone cancer	0.000152	0.00748	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—bone cancer	0.000149	0.00735	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000148	0.0073	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—bone cancer	0.000147	0.00723	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—bone cancer	0.000144	0.0071	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—bone cancer	0.000143	0.00704	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—bone cancer	0.000142	0.007	CcSEcCtD
Dalfampridine—Infection—Methotrexate—bone cancer	0.000142	0.007	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—bone cancer	0.00014	0.00691	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—bone cancer	0.00014	0.00688	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—bone cancer	0.000139	0.00685	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—bone cancer	0.000139	0.00684	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000139	0.00683	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—bone cancer	0.000135	0.00665	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—bone cancer	0.000134	0.00659	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—bone cancer	0.000134	0.00658	CcSEcCtD
Dalfampridine—Infection—Epirubicin—bone cancer	0.000133	0.00655	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—bone cancer	0.000132	0.00647	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—bone cancer	0.000131	0.00646	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—bone cancer	0.00013	0.0064	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—bone cancer	0.000129	0.00637	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—bone cancer	0.000129	0.00636	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—bone cancer	0.000129	0.00634	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—bone cancer	0.000128	0.00632	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000128	0.00632	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—bone cancer	0.000128	0.00628	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—bone cancer	0.000126	0.0062	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—bone cancer	0.000125	0.00616	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—bone cancer	0.000125	0.00615	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—bone cancer	0.000124	0.0061	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000124	0.00608	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—bone cancer	0.000123	0.00606	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—bone cancer	0.000122	0.00598	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—bone cancer	0.000121	0.00596	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—bone cancer	0.00012	0.00592	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—bone cancer	0.00012	0.00592	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—bone cancer	0.000119	0.00588	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—bone cancer	0.000118	0.0058	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—bone cancer	0.000118	0.0058	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—bone cancer	0.000116	0.0057	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000116	0.00569	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—bone cancer	0.000115	0.00564	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—bone cancer	0.000114	0.0056	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—bone cancer	0.000112	0.00552	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—bone cancer	0.000111	0.00548	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—bone cancer	0.00011	0.00544	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—bone cancer	0.00011	0.00543	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—bone cancer	0.000109	0.00537	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000107	0.00527	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—bone cancer	0.000106	0.00524	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—bone cancer	0.000106	0.00522	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—bone cancer	0.000105	0.00519	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—bone cancer	0.000103	0.00505	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—bone cancer	0.000102	0.00503	CcSEcCtD
Dalfampridine—Hypersensitivity—Epirubicin—bone cancer	9.87e-05	0.00486	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—bone cancer	9.84e-05	0.00485	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—bone cancer	9.61e-05	0.00473	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—bone cancer	9.46e-05	0.00466	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—bone cancer	9.13e-05	0.00449	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—bone cancer	9.1e-05	0.00448	CcSEcCtD
Dalfampridine—Rash—Methotrexate—bone cancer	9.02e-05	0.00444	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—bone cancer	9.01e-05	0.00444	CcSEcCtD
Dalfampridine—Headache—Methotrexate—bone cancer	8.96e-05	0.00441	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—bone cancer	8.89e-05	0.00438	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—bone cancer	8.85e-05	0.00436	CcSEcCtD
Dalfampridine—CYP2E1—Metabolism—PTGS2—bone cancer	8.61e-05	8.78e-05	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—bone cancer	8.51e-05	0.00419	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—bone cancer	8.5e-05	0.00418	CcSEcCtD
Dalfampridine—Rash—Epirubicin—bone cancer	8.44e-05	0.00416	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—bone cancer	8.44e-05	0.00415	CcSEcCtD
Dalfampridine—Headache—Epirubicin—bone cancer	8.39e-05	0.00413	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—bone cancer	8.19e-05	0.00403	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—bone cancer	7.95e-05	0.00392	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—bone cancer	7.88e-05	0.00388	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—bone cancer	7.81e-05	0.00385	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—bone cancer	7.8e-05	0.00384	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—bone cancer	7.76e-05	0.00382	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—bone cancer	7.36e-05	0.00362	CcSEcCtD
